Sign up to save your podcasts
Or
Share Kami Maddocks, MD, on the Shocking Ibrutinib Withdrawal
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Kami Maddocks, MD, on the Shocking Ibrutinib Withdrawal
In this episode of The HemOnc Pulse, Dr. Maddocks, Professor of Clinical Internal Medicine in the Division of Hematology at The Ohio State University, charts the treatment evolution of mantle cell lymphoma (MCL) from frontline therapy to future directions. She also explains her initial shock, and subsequent bittersweet reaction to the withdrawal of ibrutinib.
View all episodes
By Rahul Banerjee, MD
4.8
2727 ratings
In this episode of The HemOnc Pulse, Dr. Maddocks, Professor of Clinical Internal Medicine in the Division of Hematology at The Ohio State University, charts the treatment evolution of mantle cell lymphoma (MCL) from frontline therapy to future directions. She also explains her initial shock, and subsequent bittersweet reaction to the withdrawal of ibrutinib.